Home ›
Organizations ›
DANA-FARBER CANCER INSTITUTE
DANA-FARBER CANCER INSTITUTE
MA · Medical Research · EIN 042263040
64
Executives Disclosed
$3471.6M
Annual Revenue
$5348.9M
Total Assets
3.4:1
Internal Pay Ratio
DANA-FARBER CANCER INSTITUTE has 64 executives with disclosed compensation. The highest-paid executive, Laurie H Glimcher Md (Trustee, President & CEO), received peak total compensation of $3,994,058. The sector average for Medical Research executives is $311K.
Top Executive Compensation Over Time
Executive Compensation
| Name | Title | Peak Comp. | Latest Comp. | Years | vs. Household |
|---|---|---|---|---|---|
| Laurie H Glimcher Md | Trustee, President & CEO | $4.0M | $2.5M | 2022–2024 | 53.3x |
| Edward J Benz Jr Md | President CEO Emeritus | $2.2M | $2.2M | 2022–2022 | 29.5x |
| Glimcher Laurie H Md | Trustee, President and CEO | $2.0M | $2.0M | 2020–2020 | 26.8x |
| Glimcher Laurie Md | Trustee, President and CEO | $1.7M | $1.8M | 2017–2019 | 23.1x |
| Benz Edward J Jr Md | President and CEO Emeritus | $1.6M | $1.4M | 2017–2020 | 21.1x |
| Benz Edward | Trustee, President and CEO | $1.5M | $1.6M | 2016–2016 | 20.2x |
| William Hahn Md Phd | COO & EVP | $1.3M | $1.3M | 2022–2024 | 18x |
| Elizabeth Liebow | Former Key Employee | $1.3M | $1.3M | 2022–2024 | 16.8x |
| Michael L Reney | CFO & Assistant Treasurer | $1.1M | $1.1M | 2020–2024 | 15.3x |
| Johnson Bruce Md | Chief Clinical Research Off | $1.0M | $754K | 2016–2020 | 13.7x |
| Craig A Bunnell Md Mph Mba | Chief Medical Officer | $1.0M | $1.0M | 2022–2024 | 13.6x |
| Melany Duval | SVP & Chief Philanthropy Officer | $1.0M | $1.0M | 2022–2024 | 13.4x |
| Matthew Meyerson Md | Professor | $973K | $973K | 2022–2022 | 13x |
| Puhy Dorothy | FORMER COO & EVP | $969K | $410K | 2016–2020 | 12.9x |
| Robert Soiffer Md | Chair Executive Committee for Clinical Programs | $908K | $908K | 2022–2024 | 12.1x |
| Scott Armstrong Md Phd | Chair of Pediatric Oncology | $901K | $901K | 2023–2024 | 12x |
| Michael Constantine Md | Milford Med Dir-Hematology/Oncology | $891K | $891K | 2022–2024 | 11.9x |
| Winer Eric Md | CHIEF of Div of WMNS Cancers | $867K | $867K | 2016–2020 | 11.6x |
| Richard S Boskey Esq | Former Officer | $851K | $108K | 2022–2023 | 11.3x |
| Eric Winer Md | Chief of Div. of Women's Cancers | $845K | $845K | 2022–2022 | 11.3x |
| Bunnell Craig A Md | Chief Medical Officer | $838K | $838K | 2016–2020 | 11.2x |
| Reney Michael | CFO and Asst. Treasurer | $833K | $833K | 2016–2019 | 11.1x |
| Bruce Johnson Md | Sr. Advisor to President & CEO | $823K | $823K | 2022–2024 | 11x |
| Jeffrey Meyerhardt Md Mph | Chief Clinical Research Officer | $810K | $810K | 2022–2024 | 10.8x |
| Soiffer Robert Md | Chief of Hemotologic Malig. | $801K | $801K | 2017–2020 | 10.7x |
| Paresky Susan | FORMER SVP of Development | $799K | $149K | 2016–2020 | 10.7x |
| Constantine Michael Md | Milford Med Dir-Hematology | $785K | $785K | 2016–2020 | 10.5x |
| Griffin James D Md | PROFESSOR OF MEDICINE | $785K | $722K | 2016–2020 | 10.5x |
| Rollins Barrett J Md Phd | Chief Scientific Officer | $783K | $783K | 2016–2020 | 10.4x |
| Armstrong Scott Md | Chair of Pediatric Oncology | $779K | $779K | 2019–2020 | 10.4x |
| Nadler Lee Md | SVP for Experimental Medicine | $777K | $777K | 2016–2018 | 10.4x |
| Jennifer Willcox Esq | Asst Secretary & General Counsel | $775K | $775K | 2023–2024 | 10.3x |
| Mary-Ellen Taplin Md | Chair Executive Committee for Clinical Research | $772K | $772K | 2023–2023 | 10.3x |
| Terwilliger James | COO & EVP | $772K | $772K | 2020–2020 | 10.3x |
| Ebert Benjamin Md Phd | Chair of Med Oncology | $752K | $533K | 2018–2020 | 10x |
| James D Griffin Md | Professor of Medicine | $741K | $741K | 2022–2022 | 9.9x |
| Maria Megdal | SVP Chief Administrative Officer | $739K | $739K | 2022–2024 | 9.9x |
| Boskey Richard S Esq | Asst. SEC. & General Counsel | $731K | $731K | 2016–2020 | 9.8x |
| Kantoff Philip Md | Chief Clinical Research Ofc. | $727K | $727K | 2016–2016 | 9.7x |
| Kevin Haigis Phd | Chief Scientific Officer | $719K | $719K | 2022–2024 | 9.6x |
| Hahn William Md Phd | CHIEF OPER OFF (AS OF 7/1/20) | $715K | $679K | 2018–2020 | 9.5x |
| Duval Melany | SVP of DEVELOPMENT | $672K | $672K | 2019–2020 | 9x |
| Anderson Kenneth Md | Director, Myeloma Therapeutics | $652K | $652K | 2017–2017 | 8.7x |
| John Ryan Esq | Former Officer | $650K | $174K | 2022–2023 | 8.7x |
| Soiffer Robert J Md | Chief of Hematologic Malig. | $641K | $641K | 2016–2016 | 8.5x |
| Sallan Stephen E Md | Former Key Employee | $610K | $610K | 2016–2018 | 8.1x |
| Barrett J Rollins Md Phd | Sr. Advisor to President & CEO | $605K | $605K | 2022–2024 | 8.1x |
| Megdal Maria | SVP of Institute Operations | $571K | $571K | 2016–2020 | 7.6x |
| Stone Richard M Md | PROFESSOR OF MEDICINE | $559K | $559K | 2016–2020 | 7.4x |
| Memmott Drew | SVP Research Administration | $536K | $536K | 2016–2020 | 7.2x |
| Liebow Elizabeth | CHIEF STRATEGY OFFICER | $510K | $510K | 2018–2020 | 6.8x |
| Patricia Reid-Ponte | Former Key Employee | $500K | $500K | 2017–2017 | 6.7x |
| Wendy Gettleman | VP of Facilities Management & Real Estate | $479K | $479K | 2022–2024 | 6.4x |
| Pat Reid-Ponte | Former Key Employee | $477K | $477K | 2016–2016 | 6.4x |
| Shulman Lawrence N Md | Former Key Employee | $467K | $467K | 2016–2016 | 6.2x |
| Bird Karen | FORMER OFFICER | $462K | $461K | 2016–2020 | 6.2x |
| John O Chesley Esq | Counsel | $456K | $456K | 2023–2024 | 6.1x |
| Sylvia A Bartel Rph Mhp | SR. VP of Pharmacy & CPO | $446K | $446K | 2022–2024 | 6x |
| Gettleman Wendy | VP of Facilities Mgmt & RE | $389K | $389K | 2016–2020 | 5.2x |
| Bartel Sylvia R Ph Mhp | VP of Pharmacy Services | $378K | $378K | 2017–2020 | 5x |
| James Terwilliger | Former Officer | $361K | $361K | 2022–2022 | 4.8x |
| Drew Memmott | Former Key Employee | $341K | $341K | 2022–2022 | 4.5x |
| Bartel Sylvia Rph Mhp | VP of Pharmacy Services | $339K | $339K | 2016–2019 | 4.5x |
| Benjamin Ebert Md Phd | CHAIR OF MEDICAL ONCOLOGY | $224K | $224K | 2022–2024 | 3x |
Annual Summary
| Year | Executives | Avg. Comp. | Highest Comp. | Total Payroll |
|---|---|---|---|---|
| 2016 | 23 | $653K | $1.6M | $14.4M |
| 2017 | 23 | $671K | $1.5M | $15.4M |
| 2018 | 24 | $708K | $1.6M | $17.0M |
| 2019 | 22 | $709K | $1.8M | $15.6M |
| 2020 | 25 | $721K | $2.0M | $18.0M |
| 2022 | 24 | $851K | $4.0M | $20.4M |
| 2023 | 22 | $728K | $2.3M | $16.0M |
| 2024 | 19 | $896K | $2.5M | $17.0M |